
1. Cancer Cell. 2016 Dec 12;30(6):829-830. doi: 10.1016/j.ccell.2016.11.013.

A Novel Link between Inflammation and Cancer.

Grinberg-Bleyer Y(1), Ghosh S(2).

Author information: 
(1)Department of Microbiology & Immunology, College of Physicians and Surgeons,
Columbia University, New York, NY 10032, USA.
(2)Department of Microbiology & Immunology, College of Physicians and Surgeons,
Columbia University, New York, NY 10032, USA. Electronic address:
sg2715@cumc.columbia.edu.

Immune checkpoint-blockade treatments targeting PD-1/PD-L1 have revolutionized
cancer therapy. Hence, understanding the regulation of PD-L1 expression has major
clinical relevance. In this issue of Cancer Cell, Lim et al. report that
inflammation-induced and NF-κB-driven expression of deubiquitinating enzyme CSN5 
leads to PD-L1 stabilization and immune suppression in tumors.

Copyright © 2016 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ccell.2016.11.013 
PMID: 27960080  [Indexed for MEDLINE]

